Milestone Scientific (MLSS) Competitors $0.60 -0.07 (-10.07%) Closing price 03:59 PM EasternExtended Trading$0.60 +0.00 (+0.17%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLSS vs. SGHT, TLSI, INGN, PROF, KRMD, LNSR, ELMD, PDEX, PTHL, and RCELShould you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include Sight Sciences (SGHT), TriSalus Life Sciences (TLSI), Inogen (INGN), Profound Medical (PROF), KORU Medical Systems (KRMD), LENSAR (LNSR), Electromed (ELMD), Pro-Dex (PDEX), Pheton (PTHL), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry. Milestone Scientific vs. Its Competitors Sight Sciences TriSalus Life Sciences Inogen Profound Medical KORU Medical Systems LENSAR Electromed Pro-Dex Pheton Avita Medical Sight Sciences (NASDAQ:SGHT) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings. Which has preferable valuation and earnings, SGHT or MLSS? Milestone Scientific has lower revenue, but higher earnings than Sight Sciences. Milestone Scientific is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSight Sciences$79.87M2.30-$51.51M-$0.98-3.63Milestone Scientific$8.61M5.42-$6.93M-$0.07-8.50 Is SGHT or MLSS more profitable? Milestone Scientific has a net margin of -52.01% compared to Sight Sciences' net margin of -63.24%. Sight Sciences' return on equity of -54.62% beat Milestone Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Sight Sciences-63.24% -54.62% -34.92% Milestone Scientific -52.01%-60.26%-40.23% Do institutionals and insiders believe in SGHT or MLSS? 55.5% of Sight Sciences shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 30.9% of Sight Sciences shares are owned by company insiders. Comparatively, 24.8% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, SGHT or MLSS? Sight Sciences has a beta of 2.47, suggesting that its stock price is 147% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Do analysts rate SGHT or MLSS? Sight Sciences presently has a consensus price target of $3.93, indicating a potential upside of 10.49%. Milestone Scientific has a consensus price target of $1.25, indicating a potential upside of 110.08%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Sight Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to SGHT or MLSS? In the previous week, Sight Sciences had 4 more articles in the media than Milestone Scientific. MarketBeat recorded 5 mentions for Sight Sciences and 1 mentions for Milestone Scientific. Sight Sciences' average media sentiment score of 0.10 beat Milestone Scientific's score of -0.50 indicating that Sight Sciences is being referred to more favorably in the media. Company Overall Sentiment Sight Sciences Neutral Milestone Scientific Negative SummarySight Sciences beats Milestone Scientific on 10 of the 16 factors compared between the two stocks. Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLSS vs. The Competition Export to ExcelMetricMilestone ScientificSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$46.69M$26.87M$5.70B$21.15BDividend YieldN/AN/A4.59%3.58%P/E Ratio-8.5012.9227.9027.76Price / Sales5.422.17442.1958.69Price / CashN/A12.8036.5523.00Price / Book5.412.108.634.67Net Income-$6.93M-$5.31M$3.24B$993.85M7 Day Performance-4.05%-1.49%3.22%1.16%1 Month Performance-24.69%-8.51%10.72%4.99%1 Year Performance-38.72%-18.96%34.94%12.54% Milestone Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLSSMilestone Scientific2.9482 of 5 stars$0.60-10.1%$1.25+110.1%-38.1%$46.69M$8.61M-8.5030High Trading VolumeSGHTSight Sciences1.5946 of 5 stars$3.43-2.0%$3.93+14.7%-54.1%$180.93M$79.87M-3.50210Upcoming EarningsTLSITriSalus Life Sciences2.257 of 5 stars$4.57-0.7%$10.75+135.2%-17.5%$174.06M$29.43M-4.08106News CoverageINGNInogen4.1902 of 5 stars$6.29-0.9%$11.00+74.9%-30.1%$170.73M$335.70M-5.471,030PROFProfound Medical2.1524 of 5 stars$5.55-1.6%$11.00+98.2%-46.1%$169.50M$10.68M-4.55150News CoverageKRMDKORU Medical Systems2.1414 of 5 stars$3.46+2.7%$4.50+30.1%+36.9%$155.49M$33.65M-31.4580LNSRLENSAR1.3622 of 5 stars$13.32+1.7%$15.00+12.6%+146.9%$154.48M$53.49M-2.75110Positive NewsELMDElectromed1.1466 of 5 stars$18.13-0.5%$38.00+109.6%+22.6%$152.04M$61.44M24.17160News CoverageAnalyst UpgradeAnalyst RevisionPDEXPro-Dex1.9323 of 5 stars$46.66+1.0%$56.00+20.0%+160.8%$150.63M$64.12M16.66140PTHLPhetonN/A$22.61+1.8%N/AN/A$146.25M$450K0.0011Gap UpHigh Trading VolumeRCELAvita Medical0.929 of 5 stars$5.21+0.8%$16.50+216.7%-39.7%$136.67M$64.25M-2.38130 Related Companies and Tools Related Companies Sight Sciences Alternatives TriSalus Life Sciences Alternatives Inogen Alternatives Profound Medical Alternatives KORU Medical Systems Alternatives LENSAR Alternatives Electromed Alternatives Pro-Dex Alternatives Pheton Alternatives Avita Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MLSS) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
